Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications

The Food and Drug Administration (FDA) is requesting extension of approval of a generic for collecting information through the use of quantitative methods for studies about tobacco products. FDA will need to employ quantitative research, including surveys and experimental studies to assess knowledge and perceptions about tobacco-related topics with specific target audiences. FDA will only submit an individual generic collection for approval under this generic clearance if the individual collection meets the outlined conditions.

The latest form for Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications expires 2028-04-30 and can be found here.